Aminocaproic Acid NDC 24658-799

NDC codes

FDA NDC Directory

Product NDC (as listed)24658-799Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24658-0799Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24658-799-30	24658079930	30 TABLET in 1 BOTTLE (24658-799-30)Marketed from Jan 24, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aminocaproic Acid
Generic name (nonproprietary): aminocaproic acid
Active ingredients: Aminocaproic acid — 1000 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213928
Marketing start: Jan 24, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 24658-799_2b368d9c-2024-fecb-e063-6294a90aa87bSPL ID 2b368d9c-2024-fecb-e063-6294a90aa87bSPL set ID 7d08ad63-71f5-4286-9622-84295668a293RxCUI 197351, 476271UNII U6F3787206UPC 0324658798301, 0324658799308
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658079930 followed by a unit qualifier and the quantity

Package 24658-0799-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Aminocaproic acid is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life- threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usualIy a normal physio…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213928

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213928
Product	Strength	Form · route	Labeler	Product NDC
Aminocaproic Acid	Aminocaproic acid 500 mg/1	TabletOral	Carnegie Pharmaceuticals, LLC	80005-128
Aminocaproic Acid	Aminocaproic acid 1000 mg/1	TabletOral	Carnegie Pharmaceuticals, LLC	80005-129
Aminocaproic Acid	Aminocaproic acid 500 mg/1	TabletOral	Biocon Pharma Inc.	70377-102
Aminocaproic Acid	Aminocaproic acid 1000 mg/1	TabletOral	Biocon Pharma Inc.	70377-103
Aminocaproic Acid	Aminocaproic acid 500 mg/1	TabletOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-798